(Bloomberg) -- An exodus from defensive plays made Swiss equities lag most developed markets this quarter, sending the number of outstanding bearish options to an eight-year high versus contracts betting on gains. A run into companies including Novartis AG and Roche Holding AG in the immediate aftermath of the Brexit vote pushed Swiss valuations to the highest since 2008 relative to their euro-area peers. “At a certain point you start taking a chance with other stocks -- there are just more opportunities out there,” said Ion-Marc Valahu, co-founder and fund manager at Clairinvest in Geneva.
To contact the reporter on this story: Roxana Zega in Zurich at rzega@bloomberg.net. To contact the editors responsible for this story: Cecile Vannucci at cvannucci1@bloomberg.net, Alan Soughley, Nancy Moran
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
